Shenzhen Chipscreen Biosciences Co Capital Reinvestment Ratio
Shenzhen Chipscreen Biosciences Co capital reinvestment ratio. Shenzhen Chipscreen Biosciences Co (688321) has a Capital Reinvestment Ratio of 27.48x as of September 2025, meaning it reinvests 27% of its operating cash flow (CN¥2.25 Million) in capital expenditures (CN¥61.73 Million). Check how aggressively does Shenzhen Chipscreen Biosciences Co reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Shenzhen Chipscreen Biosciences Co (2016–2024)
Capital reinvestment ratio of Shenzhen Chipscreen Biosciences Co from 2016 to 2024. This chart tracks Shenzhen Chipscreen Biosciences Co's Capital Reinvestment Ratio across 7 annual periods. Also explore 688321 net assets growth trend to track the company's year-over-year net asset growth rate.
Shenzhen Chipscreen Biosciences Co Capital Reinvestment Ratio by Year (2016–2024)
Shenzhen Chipscreen Biosciences Co capital reinvestment ratio by year from 2016 to 2024. For the full cash flow conversion analysis, see how efficiently does Shenzhen Chipscreen Biosciences Co generate cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 3.53x | CN¥76.13 Million | CN¥268.49 Million | ▼ -61.8% |
| 2022 | 9.24x | CN¥43.30 Million | CN¥400.17 Million | ▲ +299.8% |
| 2021 | 2.31x | CN¥124.78 Million | CN¥288.46 Million | ▼ -35.6% |
| 2020 | 3.59x | CN¥93.62 Million | CN¥336.27 Million | ▼ -41.9% |
| 2018 | 6.18x | CN¥22.78 Million | CN¥140.74 Million | ▼ -87.3% |
| 2017 | 48.65x | CN¥2.73 Million | CN¥132.82 Million | ▲ +4318.2% |
| 2016 | 1.10x | CN¥59.77 Million | CN¥65.81 Million | — |